Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CMPX..........................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
https://finance.yahoo.com/news/tovecimig-ctx-009-meets-primary-110000152.html
"We are thrilled to share these positive primary endpoint data from the COMPANION-002 study of tovecimig in patients with advanced biliary tract cancer," said Thomas Schuetz, MD, PhD, CEO of Compass and Vice Chairman of the Board of Directors. “We would like to thank all of the patients and their caregivers who have participated and continue to participate in this study. We believe these findings highlight the potential of tovecimig to provide a much-needed treatment option for the majority of patients with BTC who have limited alternatives after first-line therapy. We look forward to discussing these data with regulatory authorities."
“As a treating clinician for over 20 years, I have seen firsthand how challenging a disease biliary tract cancer is. Patients currently have very limited treatment options, with the vast majority in the second-line setting having no approved therapeutic alternative whatsoever. For every statistic there is a person – a mother, father, relative, or friend – fighting for more time. Each investigative trial helps in this fight to advance new treatment options, and I look forward to following tovecimig’s continued progress,” said Juan Valle, MD, Chief Medical Officer of the Cholangiocarcinoma Foundation.
looks like we get the read out news in the AM .. and either it builds some really nice buying pressure... or its not great news and this thing dives. surprise this one is so quiet.
Man! It has been some time! You are one of the few money makers that I have met on ihub. I always appreciate and laugh at your lack of tolerance for stupidity.
Need your thoughts as I know u r more technical, but the fundamentals behind this name are scary good. This low float could run massively (sound like 47) as they have cash until 2027 and about to potentially get some solid results from their phase 2/3 study. I have simply tripled my money waiting....
Yep, seems like it makes a new 52 week high 3-4 times a week. Someone must know something
What does this tell us? Thanks
CMPX............................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
What does this tell you? Thanks!
CMPX...........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
the upcoming trials....apparently someone(s) may know the results? The initial indication is that they were very good
listen to the webcasts and you will find mindblowing things every now and then. Like 6 out of 22 patients with 40% tumor decline in vegf dll4 monotherapy data.
And some people say theres a way to make the machine listen.
Someone must know something....
CMPX........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
and they didnt even speak about it today!
Some very good news out this morning!
CMPX..................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
sideways................higher lows.....possible breakout
What does your work tell you on this? Thanks
cmpx.........................https://stockcharts.com/h-sc/ui?s=cmpxp=W&b=5&g=0&id=p86431144783
Sorry for the late reply, your question got lost in the mailbox.
I believe 3-6$ isnt unreasonable if they publish a nice readout.
i believe a handful of patients showed more than 30% tumor shrinkage in vegf monotherapy data... I havent seen similar to date...... Nobody listens to webcasts anymore - they probably need an anaylst note to alert them LOL
VEGf space is full of scammers to... everyone jumped the train
If so, where do you think that puts the stock? Thanks
Wouldnt be surprised to see a partner announced in the 10q
boom coming never before monotherapy data in VEGF space.... a place flooded by bio grifters
EXCELLENT monotherapy data
VEGF targeted agents usually need the chemo combination to even get a signifcant response. They get it in monotherapy.
I think its going to run into the H1 2025 data.
CMPX........................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
CMPX....................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
CMPX....................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
Cant say offhand
Read the latest 10Q
Do you know there current cash on hand?
Followers
|
3
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
77
|
Created
|
11/30/05
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |